Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease

Tau pathology, neuroinflammation, and neurodegeneration are key aspects of Alzheimer’s disease. Understanding whether these features predict cognitive decline, alone or in combination, is crucial to develop new prognostic measures and enhanced stratification for clinical trials. Here, we studied how...

Descripción completa

Detalles Bibliográficos
Autores principales: Malpetti, Maura, Kievit, Rogier A, Passamonti, Luca, Jones, P Simon, Tsvetanov, Kamen A, Rittman, Timothy, Mak, Elijah, Nicastro, Nicolas, Bevan-Jones, W Richard, Su, Li, Hong, Young T, Fryer, Tim D, Aigbirhio, Franklin I, O’Brien, John T, Rowe, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241955/
https://www.ncbi.nlm.nih.gov/pubmed/32380523
http://dx.doi.org/10.1093/brain/awaa088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241955/
https://www.ncbi.nlm.nih.gov/pubmed/32380523
http://dx.doi.org/10.1093/brain/awaa088

Ejemplares similares